CClinicalTrials.gg
CompletedNCT04751240Updated Feb 12, 2021

Effect of Interval and Resistance Exercise on Physiological and Psychological Parameters.

An interventional study of SIT and resistance training in Body Composition, sponsored by Auburn University. Completed at 1 site in United States. Open to female participants aged 25 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-02-12.

Sponsored by Auburn University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years after the study started (first participant enrolled Jan 2019, registered Feb 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Not applicable
Ages
25 Years to 55 Years
Sex
Female
01

Study summary

The purpose of this study is to examine the physiological and psychological effects of a sprint interval and resistance training intervention on females.

Read the detailed description

Females aged 20-65 will attend 10 weeks of exercise training consisting of sprint interval training and resistance training for 30 sessions. We will examine changes in body composition, blood panel (fasting glucose, cholesterol, triglycerides), strength (bench press and back squat), aerobic capacity and psychological parameters (hardiness, affect, enjoyment, perception and self-regulation). The effects will be measured acutely after the program and 6-months after the cessation of the program.

02

Conditions studied

  • Body Composition
03

In context

Lead sponsor

Auburn University is the lead sponsor of 72 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 55 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • This population consists of: females, aged 25-55, who are: sedentary (not reporting a regular schedule of exercise over the last 3 months), and able to start an exercise program (assessed by the PARQ+)

Exclusion criteria

Exclusion Criteria:

  • Females who are below age 25 or over age 55, who are currently exercising and have existing conditions that would exclude them from exercise.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
42 participants (actual)

Study arms

  • Experimental
    SIT and Resistance

    Participants will complete 10 weeks of a SIT and resistance training paradigm.

    Behavioral: SIT and resistance training

Interventions

  • BehavioralSIT and resistance training

    Participants complete 30 sessions of sprints and resistance training. Outcomes are assessed acutely and at 6 months.

06

What researchers measure

Primary outcomes

  1. Fat mass post

    Changes in Fat mass in Kg assessed by idexa

    Time frame: Change in fat mass at 13 weeks

  2. Fat mass retention

    Changes in Fat mass in Kg assessed by idexa

    Time frame: Change in fat mass at 6 months

  3. Lean mass post

    Changes in Lean mass in Kg assessed by idexa

    Time frame: Change in lean mass at 13 weeks

  4. Lean mass retention

    Changes in Lean mass in Kg assessed by idexa

    Time frame: Change in lean mass at 6 months

  5. Visceral Fat post

    Changes in Visceral Fat in Kg assessed by idexa

    Time frame: Change in visceral fat at 13 weeks

  6. Visceral Fat retention

    Changes in Visceral Fat in Kg assessed by idexa

    Time frame: Change in visceral fat at 13 weeks

  7. Participate perception of the program post

    Interviews to assess participants perception of the program

    Time frame: 13 weeks

  8. Participate perception of the program retention

    Interviews to assess participants perception of the program

    Time frame: 6 months

Secondary outcomes

  1. Strength - bench press

    Changes in bench press measured in Kg

    Time frame: Change in bench press at 13 weeks

  2. Strength - back squat

    Changes in back squat measured in Kg

    Time frame: Change in back squat at 13 weeks

  3. Blood glucose post

    Changes in fasting blood glucose

    Time frame: Changes in fasting blood glucose at 13 weeks

  4. Blood glucose retention

    Changes in fasting blood glucose

    Time frame: Changes in fasting blood glucose at 6 months

  5. Cholesterol post

    Changes in Cholesterol

    Time frame: Changes in Cholesterol at 13 weeks

  6. Cholesterol retention

    Changes in Cholesterol

    Time frame: Changes in Cholesterol at 6 months

  7. Triglycerides post

    Changes in Triglycerides

    Time frame: Changes in Triglycerides at13 weeks

  8. Triglycerides retention

    Changes in Triglycerides

    Time frame: Changes in Triglycerides at 6 months

07

Study locations

1 site
  • School of Kinesiology
    Auburn, Alabama 36830, United States
08

References and documents

Individual participant data

Plan to share: No — No IPD will be shard with other researchers.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 12, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04751240
Lead sponsor
Auburn University
Responsible party
Danielle D Wadsworth (Associate Professor, Auburn University) — Principal investigator
First posted
Feb 12, 2021
Start date
Jan 20, 2019
Primary completion
Dec 31, 2020
Completion
Dec 31, 2020
Last update
Feb 12, 2021

Study contacts

Danielle Wadsworth, PhD
principal investigator · Auburn University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion